Lazard Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-25,647
Closed -$2.55M 1737
2019
Q3
$2.55M Hold
25,647
﹤0.01% 637
2019
Q2
$2.37M Buy
+25,647
New +$2.44M ﹤0.01% 737
2019
Q1
Sell
-141,337
Closed -$9.06M 1239
2018
Q4
$9.06M Sell
141,337
-39,526
-22% -$2.92M 0.02% 427
2018
Q3
$16.2M Buy
180,863
+21,697
+14% +$1.92M 0.03% 341
2018
Q2
$12.6M Sell
159,166
-217,591
-58% -$18.1M 0.02% 383
2018
Q1
$33.6M Sell
376,757
-13,609
-3% -$1.31M 0.06% 215
2017
Q4
$40.7M Sell
390,366
-1,277,079
-77% -$144M 0.07% 196
2017
Q3
$243M Buy
1,667,445
+156,471
+10% +$21.3M 0.44% 58
2017
Q2
$196M Buy
1,510,974
+457,563
+43% +$56.1M 0.37% 67
2017
Q1
$131M Sell
1,053,411
-34,372
-3% -$4.11M 0.25% 79
2016
Q4
$126M Sell
1,087,783
-127,910
-11% -$14.2M 0.26% 80
2016
Q3
$127M Sell
1,215,693
-85,401
-7% -$9.24M 0.25% 83
2016
Q2
$128M Buy
1,301,094
+1,247,397
+2,323% +$129M 0.27% 86
2016
Q1
$5.37M Sell
53,697
-25,921
-33% -$2.67M 0.01% 486
2015
Q4
$9.53M Sell
79,618
-61,360
-44% -$7.1M 0.02% 405
2015
Q3
$15.2M Buy
140,978
+5,369
+4% +$666K 0.04% 280
2015
Q2
$15.7M Buy
135,609
+25,726
+23% +$2.94M 0.03% 295
2015
Q1
$12.7M Buy
109,883
+7,895
+8% +$943K 0.03% 326
2014
Q4
$11.4M Sell
101,988
-27,694
-21% -$2.92M 0.02% 374
2014
Q3
$12.3M Buy
129,682
+1,258
+1% +$114K 0.03% 335
2014
Q2
$11M Buy
128,424
+1,008
+0.8% +$76.7K 0.02% 377
2014
Q1
$8.89M Buy
127,416
+36
+0% +$2.85K 0.02% 394
2013
Q4
$10.8M Sell
127,380
-28,232
-18% -$2.23M 0.02% 351
2013
Q3
$12M Buy
155,612
+6,054
+4% +$424K 0.03% 322
2013
Q2
$8.74M Buy
+149,558
New +$9M 0.02% 393

Other funds holding CELG

Lazard Asset Management's CELG Position: Q4 2019 in Review

Lazard Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 25,647 shares — an estimated $2.55M sold.

Lazard Asset Management first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $243M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Lazard Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Lazard Asset Management sold 25,647 Celgene Corp shares in Q4 2019, an estimated $2.55M.
  • Lazard Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Lazard Asset Management's Celgene Corp position peaked at $243M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Lazard Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.